Berlin Halts AstraZeneca Jab As Germany Weighs Limiting It To Older Patients

The spread of SARS-CoV-2 and the confirmed “mutant” strains has accelerated (though daily numbers remain well below their record highs reached in late January) over the past month, and just after the European Union finally reached a deal with the UK to try and ensure vaccine “reciprocity” (at least for developed, wealthy, western countries). But more than a week after troubled vaccine-maker AstraZeneca released a revised analysis of its Phase 3 research following a squabble with an obscure US regulator, German Capital Berlin has just announced that it’s banning jabs going to patients over the age of 60.

Continue reading the original article here. Archived here.